While our results provide new avenues for research into the 3D spatio-temporal organization of the genome in diabetes, in vivo analyses that incorporate proximity-ligation and empirical perturbation (e.g., using CRISPR–Cas) are required to definitively prove the role for these connections in T2D disease development. The gene discussed is BCAR1; the disease is type 2 diabetes mellitus.